Tuilpakov. A N AN; Bulatov. A A AA; Peterkova. V A VA; Elizarova. G P GP; Volevodz. N N NN; Bowers....
In a small study of kids with short stature, a single IV dose of the peptide GHRP-2 raised growth hormone (GH) levels about as well as the natural hormone GHRH in children who were otherwise healthy, but it barely worked in kids who already had GH deficiency.
The study shows that GHRP-2 triggers growth hormone release in rat pituitary cells just like GHRP-6, works best when paired with growth hormoneâreleasing factor (GHRF), and doesnât give extra benefit when both GHRPâ2 and GHRPâ6 are taken together. The two peptides can make each other less effective over time, but they donât affect the response to GHRF.
Nijland. E A EA; Strasburger. C J CJ; Popp-Snijders. C C; van der Wal. P S PS; van der Veen. E A EA
In a small study of nine healthy young men, daily injections of 100âŻÂ”g GHRPâ2 for five days kept releasing growth hormone, but the hormone spikes got smaller each day. After five days there was no rise in the blood level of IGFâI (the downstream hormone linked to many antiâaging claims), although a boneârelated marker called osteocalcin did go up.
In sheep pituitary cells, the growthâhormoneâreleasing peptide GHRPâ2 triggers GH release by activating both the PKC and the classic cAMPâPKA pathways, and these two signaling routes help each other. Blocking PKC or PKA reduces the GHâboosting effect of GHRPâ2, showing both are needed for full activity.
Tiulpakov. A N AN; Brook. C G CG; Pringle. P J PJ; Peterkova. V A VA; Volevodz. N N NN; Bowers. C Y...
In a tiny study of eight healthy young men, a single IV dose of the peptide GHRPâ2 caused a much bigger spike in growth hormone (GH) than the natural hormone GHRH, and mixing the two didnât make the effect any stronger than just adding their separate effects together.
Nakagawa. T T; Ukai. K K; Ohyama. T T; Koida. M M; Okamura. H H
In a rat study, the synthetic peptide KP-102 (a version of GHRPâ2) was able to boost growth hormone (GH) levels, even in rats that normally produce very little GH. The effect was strongest when the peptide was given directly into the brain or pituitary, but it still worked when injected into the bloodstream. However, the boost was much smaller than in normal rats, and the research was done only in anesthetized animals.
Hashizume. T T; Sasaki. K K; Kobayashi. S S; Nitta. Y Y
In goats, directly delivering GHRP-2 into the brainâs hypothalamus caused a clear rise in growth hormone levels, showing that the peptide can act on the brain to boost GH release. This effect was seen without changing how often GH pulses occurred, but each pulse was larger. The study also showed that simply putting growthâhormoneâreleasing hormone (GHRH) into the hypothalamus didnât work the same way, highlighting a unique action of GHRPâ2.
The paper says that new growthâhormoneâreleasing drugs like GHRPâ2 can boost GH without injections, even when taken as a pill or nasal spray, and they seem safe. In thalassemia patients who have low GH despite a normal pituitary, these drugs give a stronger, longerâlasting GH surge, making them a possible treatment.
Pihoker. C C; Badger. T M TM; Reynolds. G A GA; Bowers. C Y CY
A small study gave kids with short stature a nasal spray of GHRPâ2 twice or three times daily. After a few months they grew faster (about 2â3âŻcm more per year) and the treatment was well tolerated, but blood levels of IGFâ1 didnât change and the hormone spikes stayed the same.
Roh. S G SG; He. M L ML; Matsunaga. N N; Hidaka. S S; Hidari. H H
The study shows that GHRPâ2 directly triggers growth hormone release from cow pituitary cells and that its effect adds up with the natural hormoneâreleasing factor (GHRF). The hormone boost depends on calcium entering the cells and involves proteinâkinase C and cAMP signaling pathways. Blocking calcium channels, the GHRF receptor, or adding somatostatin reduces the effect.
Muccioli. G G; Broglio. F F; Valetto. M R MR; Ghè. C C; Catapano. F F; Graziani. A A; Papotti....
Growth hormoneâreleasing peptides (like GHRPâ2) donât just boost GH â they also stick to heart tissue and can protect heart cells, improve heart pumping strength, and reduce damage from lowâoxygen events, even without involving GH.
McDowell. R S RS; Elias. K A KA; Stanley. M S MS; Burdick. D J DJ; Burnier. J P JP; Chan. K S KS; Fa...
Scientists reshaped a growthâhormoneâreleasing peptide (GHRPâ2) to make it even smaller and more powerful. In lab tests and animal studies the new versions triggered strong GH release and helped build muscle when given intermittently. They also mapped the 3âD shape of the bestâworking version, giving clues for designing even better lowâweight secretagogues.
The study shows that the peptide GHRP-2 (and its sibling GHRP-6) can directly make human fetal pituitary cells release growth hormone, though itâs less powerful than the natural hormone GHRH. When both peptides are used together, they add up their effects but donât boost each other beyond that. The peptide doesnât change other hormones like ACTH or prolactin and can counteract the suppressive actions of IGFâ1 or somatostatin.
Pihoker. C C; Kearns. G L GL; French. D D; Bowers. C Y CY
A small study gave kids with short stature a single tiny IV dose of GHRPâ2 and measured how the drug and growth hormone behaved in their blood. The peptide reliably boosted growth hormone levels, and the researchers worked out how fast it clears, how much spreads in the body, and the dose needed to get halfâmaximal effect (EC50). This data can help design future dosing schedules, especially for nonâIV routes.
The paper explains that adult growth hormone deficiency (aGHD) often follows brain injuries like trauma or bleeding in the brain. It describes how a special test using the peptide GHRPâ2 can safely and quickly measure a personâs ability to release growth hormone, and it notes that growthâhormone replacement can improve body composition, strength, and overall health in deficient patients.
Kamegai. J J; Hasegawa. O O; Minami. S S; Sugihara. H H; Wakabayashi. I I
A new version of the growthâhormoneâreleasing peptide (KPâ102, similar to GHRPâ2) was shown to activate specific brain cells in the arcuate nucleus that are known to make growthâhormoneâreleasing factor (GRF). This suggests the peptide works partly by stimulating the brain, not just the pituitary gland.
Pihoker. C C; Middleton. R R; Reynolds. G A GA; Bowers. C Y CY; Badger. T M TM
The study shows that GHRPâ2, given either by IV or as a nasal spray, reliably triggers a strong growthâhormone surge in children with short statureâabout the same as the classic hormone GHRH. A nasal dose of 5â20âŻÂ”g per kg (â15âŻÂ”g/kg gave the biggest average spike) worked well and was well tolerated, and mixing GHRPâ2 with GHRH gave an even bigger, synergistic response.
Muccioli. G G; Ghè. C C; Ghigo. M C MC; Papotti. M M; Arvat. E E; Boghen. M F MF; Nilsson. M H...
The study shows that synthetic growthâhormone secretagogues like GHRPâ2 bind to specific highâaffinity receptors in the human pituitary and several brain areas, especially the hypothalamus. This suggests these peptides can act directly in the brain, not just on the pituitary, and may influence GH release and possibly other brain functions.
Ankersen. M M; Johansen. N L NL; Madsen. K K; Hansen. B S BS; Raun. K K; Nielsen. K K KK; Thogersen....
Scientists made new versions of the growthâhormoneâreleasing peptide ipamorelin that can be taken by mouth. One of them, called NNCâŻ26â0235, works as well as the classic GHRPâ2/6 in animals and shows about 10% oral bioavailability, meaning a small but measurable amount gets into the bloodstream when you swallow it.
Shibasaki. T T; Yamauchi. N N; Takeuchi. K K; Ishii. S S; Sugihara. H H; Wakabayashi. I I
In rats, the growth hormone secretagogue KP-102 (similar to GHRPâ2) makes animals eat more, but only when they are already fed. If the rats have been fasting for a day, the drug doesn't boost eating. Stress reduces food intake, yet giving KP-102 directly into the brain can partly reverse that drop. Adding somatostatin (a hormone that blocks growth hormone) weakens KP-102's appetiteâboosting effect, though somatostatin alone doesn't change eating.